【摘 要】
:
Although adenocarcinomas of the prostate are relatively indolent, some patients with advanced adenocarcinomas show recurrence of treatment?induced neuroendocrine prostate cancer, which is highly aggressive and lethal. Detailed biological features of treat
【机 构】
:
School of Life Sciences, Anhui University, Hefei, China;Department of Pathology and Laboratory Medic
论文部分内容阅读
Although adenocarcinomas of the prostate are relatively indolent, some patients with advanced adenocarcinomas show recurrence of treatment?induced neuroendocrine prostate cancer, which is highly aggressive and lethal. Detailed biological features of treatment?induced neuroendocrine prostate cancer have not been characterized owing to limited biopsies/resections and the lack of a cellular model. In this study, we used a unique cellular model (LNCaP/NE1.8) to investigate the potential role of cancer stem cells in treatment?induced neuroendocrine prostate cancer with acquired resistance to hormonal therapy and chemotherapy. We also studied the role of cancer stem cells in enhancing invasion in treatment?induced neuroendocrine prostate cancer cells that recurred after long?term androgen?ablation treatment. Using an in vitro system mimicking clinical androgen?ablation, our results showed that the neuroendocrine?like subclone NE1.8 cells were enriched with cancer stem cells. Compared to parental prostate adenocarcinoma LNCaP cells, NE1.8 cells are more resistant to androgen deprivation therapy and chemotherapeutic agents and show increased cancer cell invasiveness. Results from this study also suggest a potential epigenetic therapeutic strategy using suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, as a chemotherapeutic agent for therapy?resistant treatment?induced neuroendocrine prostate cancer cells to minimize the risk of prostate cancer recurrence and metastasis.
其他文献
The fact that most men are severely distressed by pharmaceutical and/ or surgical treatments resulting in functional castrations is inherently obvious.Unfortunately,significant male infertility,predictable after some types of treatment,is often not consid
Both pulsatile gonadotropin?releasing hormone (GnRH) infusion and combined gonadotropin therapy (human chorionic gonadotropin and human menopausal gonadotropin [HCG/HMG]) are effective to induce spermatogenesis in male patients with congenital hypogonadot
Researchers reporting in the Nature journal Scientific Reports1 have used next generation sequencing and quantitative reverse transcriptase PCR (RT-PCR) technology to profile plasma microRNA (miRNA) expression in cohorts of men with and without late-onset
To evaluate the clinical efifcacy of a procedure comprising a combination of Percoll continuous density gradient and modiifed swim?up techniques for the removal of human immunodeifciency virus type 1 (HIV?1) from the semen of HIV?1 infected males, a total
Symptomatic seminal vesicle cysts (SVCs),especially those of a large size,can be removed by surgical treatments.Currently,open surgeries for SVC are rarely performed due to their extensive surgical trauma,and minimally invasive surgical therapies for trea
Dear Editor,rnMale infertility, which affects approximately 20 million people worldwide, is commonly caused by spermatogenic dysfunctions, including severe oligozoospermia, cryptozoospermia, and nonobstructive azoospermia, which are largely genetic in ori